FDA grants breakthrough research to Psilocybin

SOURCE: COMPASS Pathways 

https://www.prnewswire.com/news-releases/compass-pathways-receives-fda-breakthrough-therapy-designation-for-psilocybin-therapy-for-treatment-resistant-depression-834088100.html

 

 

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.